Equine Rotavirus Vaccine, Killed Virus

Company: Zoetis

For the vaccination of pregnant mares 2 years of age or older to provide passive transfer of antibodies to their foals against equine rotavirus. This product license is conditional; efficacy and potency have not been fully demonstrated. For more information regarding safety data, go to productdata.aphis.usda.gov.

For use by, or under the supervision of, a veterinarian.

Directions For Use

Shake well. Aseptically administer 1 mL intramuscularly to pregnant mares at the eighth month of pregnancy. Administer a second 1-mL dose at the ninth month of pregnancy and a third 1-mL dose at the tenth month of pregnancy. Historically, revaccination with three doses at each subsequent pregnancy was recommended; consultation with a veterinarian or the manufacturer is recommended.

Precautions

Store in the dark at 2°-8°C. Do not freeze. Use entire contents when first opened. Contains thimerosal, neomycin, polymyxin B and amphotericin B as preservatives. Do not vaccinate within 21 days before slaughter. In case of anaphylactoid reaction, administer epinephrine. Do not mix with other products. In case of human exposure, contact a physician.

Technical inquiries: (888) 963-8471.

VLN 190/PCN 1E15.20

Zoetis Inc., Kalamazoo, MI 49007, USA

CPN: 3690282.4